SPRO compared with LYEL: revenue, margins and what each company keeps, and the suppliers and customers both name

SPROSpero Therapeutics, Inc.

Mkt capRevenueRevenue

LYELLyell Immunopharma, Inc.

Mkt capRevenueRevenue

Compare

SPROSpero Therapeutics, Inc.

LYELLyell Immunopharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SPRO: latest quarter is a loss; flow not drawable. LYEL: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SPRO 7

PFEPfizersupplier

GSKGSKcustomer

—Meijiunlistedsupplier

—Cantab Anti-Infectivesunlistedsupplier

3 more · SPRO chain ›

Shared 0

No shared counterparties.

Only LYEL 11

—City of Hope Comprehensive Cancer Centerunlistedsupplier

—Dana Farber Cancer Instituteunlistedsupplier

—Innovative Cellular Therapeutics Holdings Limited and Innovative Cellular Therapeutics, Inc. (together, ICT)unlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

supplier

—Miltenyi CliniMACS PRODIGY ®unlistedsupplier

7 more · LYEL chain ›

Price

rebased to 0%

SPRO, solidLYEL, dashed

SPROSpero Therapeutics, Inc.

1.07▼−3.91%· post 1.07

Mkt cap$61.7MRevenue$258,000Q1 FY26Revenue$67MFY25

LYELLyell Immunopharma, Inc.

10.96▼−3.03%· post 10.96

ClosedOct 30 '26

Mkt cap$270.5MRevenue$4,000Q2 FY26Revenue$36,000FY25

Compare

ClosedOct 30 '26

SPROSpero Therapeutics, Inc.

LYELLyell Immunopharma, Inc.

1.07▼−3.91%post 1.07

Price

10.96▼−3.03%post 10.96

$61.7M

Mkt cap

$270.5M

Q1 FY26$258,000

Revenue

$4,000Q2 FY26

FY25$67M

Revenue

$36,000FY25

SPRO1.07▼−3.91%vsLYEL10.96▼−3.03%ClosedOct 30 '26